Danielle Delaney

Danielle Delaney serves as a procurement professional responsible for managing complex acquisitions within the federal health and life sciences sector. She plays a critical role in executing strategic sourcing initiatives aligned with national public health priorities, overseeing the acquisition of pharmaceutical and biological products essential to federal medical programs. Her work involves end-to-end contract management—from requirements definition and market research to solicitation, evaluation, and award—ensuring compliance with federal acquisition regulations and mission-critical supply chain integrity. Delaney typically handles high-compliance, technical procurements requiring deep regulatory knowledge and coordination with scientific and clinical stakeholders. Her contractor relationships are primarily with manufacturers and contract development and manufacturing organizations (CDMOs) specializing in pharmaceutical and biological product production. While no single vendor dominates her portfolio, she consistently engages with firms possessing cGMP certification, FDA-registered facilities, and robust quality assurance systems. Her contracting patterns reflect a preference for established industry players with proven track records in sterile manufacturing, cold chain logistics, and biologics development, often requiring stringent validation and inspection protocols. Delaney demonstrates a strong commitment to small business participation, with 17.8% of her awards designated as total small business set-asides under FAR 19.5. While she does not frequently utilize specialized socioeconomic programs like 8(a), HUBZone, or SDVOSB, her consistent use of small business set-asides signals a deliberate effort to expand market access for qualified small manufacturers in the life sciences space. Her primary procurement focus lies in NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 325414 (Biological Product Manufacturing), reflecting deep expertise in procuring injectables, vaccines, and other therapeutic biologics. She also manages limited acquisitions under 315210 for specialized protective apparel. Her technical domain expertise centers on regulatory compliance, supply chain resilience, and the unique manufacturing requirements of FDA-regulated products.